Mvm Partners

Venture Capital Exempt reporting adviser

Legal name: Mvm Partners, LLC

Boston, MA Website

AUM

$1.0B
Private fund assets

Private funds

10
Venture Capital 10

Private fund assets

$1.0B
Gross asset value

Employees

—

Last Form D raise

Dec 2022
Most recent fund filing

From SEC Form ADV filing (filed Jun 29, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

K
Kevin Cheng
Member
Source: SEC Form ADV
K
Kyle Dempsey
Member
Source: SEC Form ADV
S
Stephen Reeders
President
Source: SEC Form ADV

Funds(10)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Mvm V (2021) LPVenture Capital$48.0M$11.6M11Dec 2022Cold
Mvm A LPVenture Capital$18.0M$6.5M7Dec 2022Cold
Mvm D LPVenture Capital$16.7M——Dec 2022Cold
Mvm C LPVenture Capital$15.1M$7.5M12Dec 2022Cold
Mvm E LPVenture Capital$7.2M——Dec 2022Cold
Mvm F LPVenture Capital$183K——Dec 2022Cold
Mvm III (2020) LPVenture Capital$100K$4.3M2Dec 2022Cold
Mvm V (2020) LPVenture Capital$60K$46.5M7Dec 2022Cold
Mvm VI LPVenture Capital$577.0M$259.9M57Nov 2022Cold
Mvm V LPVenture Capital$322.1M$141.5M38Oct 2018Cold

Board seats(1)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Ambio Holdings
BiotechnologyNorth Augusta, SCDirector: Stephen Reeders
$24.0M raised
Since Nov 2014
SEC Form D

Regulatory identifiers

CRD number
159225
SEC file number
802-74926

Sources